Outset Medical (OM) Preferred Stock Liabilities (2019 - 2020)
Outset Medical (OM) posted quarterly Preferred Stock Liabilities of $452.3 million for Q2 2020, little changed quarter-over-quarter from $452.3 million in Q1 2020.
Outset Medical (OM) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends
Outset Medical (OM) has reported Preferred Stock Liabilities for 2 consecutive years, with $452.3 million the latest figure, recorded in Q2 2020.
- In Q2 2020, Preferred Stock Liabilities changed N/A year-over-year to $452.3 million; the TTM figure through Jun 2020 stood at $452.3 million (changed N/A YoY), while the FY2019 annual figure was $409.4 million, up 4.37% from the prior year.
- Preferred Stock Liabilities held at $452.3 million in Q2 2020 per OM's latest filing, from $452.3 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $452.3 million in Q1 2020 and bottomed at $409.4 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Outset Medical | 80.25 Mn | -182.94 Mn | 13.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 452.27 Mn |
| Mar 31, 2020 | 452.27 Mn |
| Dec 31, 2019 | 409.45 Mn |
| Sep 30, 2019 | 409.45 Mn |